From a mechanisticstandpoint, PPARδ is activated in colon cancer cells by prostacyclin (PGI2)[82] and inhibited by the NSAIDindomethacin [75], suggesting that its tumorpromoting action is related to inflammation, a condition that increases therisk of colon cancer [83]. Here, PPARD is linked to malignant colon neoplasm.